EPIVIR
- Product NDC
- 50090-0550
- 11-digit product format
- 500900550
- Labeler code
- 50090
- Product ID
- 50090-0550_919f0d67-a0da-4ad8-a12a-e0c0922cd4be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA020564
- Marketing category
- NDA
- Marketing start
- 2010-10-04
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record